Abstract #0434
GluCEST in the olfactory cortex as a marker of heightened clinical risk for schizophrenia
Ravi Prakash Reddy Nanga 1 , David R. Roalf 2 , Hari Hariharan 1 , Mark A. Elliott 1 , Karthik Prabhakaran 2 , Megan Quarmley 2 , Paul J. Moberg 2 , Ravinder Reddy 1 , and Bruce I. Turetsky 2
1
Radiology, University of Pennsylvania Health
Systems, Philadelphia, Pennsylvania, United States,
2
Psychiatry,
University of Pennsylvania, Philadelphia, Pennsylvania,
United States
In vivo measurement of glutamate neurotransmitter levels
in brain structures implicated in neuropsychiatry
disorders may provide insight into the role of these
structures play in the manifestation of symptoms and
potentially lead to improvements in therapy. Recent,
studies with methods based on glutamate chemical
exchange saturation transfer (GluCEST) in animal models
and humans suggest that GluCEST mapping may serve as a
biomarker of brain glutamate distribution, in vivo.
Here, we use GluCEST to map glutamate distributions,
within olfactory cortex, in healthy individuals (HC) and
individuals at clinical risk for developing
schizophrenia (CR).
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
